Promoter polymorphism of the beta2 bradykinin receptor gene is associated with essential hypertension

Jpn Circ J. 1999 Oct;63(10):759-62. doi: 10.1253/jcj.63.759.

Abstract

The present study examined the genetic contribution of the human beta2 bradykinin receptor gene in Japanese subjects with essential hypertension, and identified a -58T/C polymorphism of the core promoter that might be responsible for essential hypertension in Japanese. The study consisted of 100 hypertensive subjects and 100 age- and sex-matched controls. The allelic frequencies were 0.575 for the C allele and 0.425 for the T allele in hypertensive subjects, and 0.465 for the C allele and 0.535 for the T allele in normotensive subjects. The allelic frequencies were in Hardy-Weinberg equilibrium. Significant differences between hypertensive and normotensive subjects were seen in the genotypes distribution (p=0.049) and allelic frequencies (p=0.028), and the beta2 bradykinin receptor gene variant was associated with human essential hypertension in this Japanese population. This new marker may provide a valuable tool for assessing the risk for putative bradykinin-associated common diseases, such as hypertension, and cardiovascular diseases with genetic determinism. These results suggest that the -58 polymorphism of the human beta2 bradykinin receptor gene is an independent risk factor for essential hypertension in the Japanese population.

MeSH terms

  • Adult
  • Alleles
  • Female
  • Gene Frequency
  • Genes / genetics
  • Humans
  • Hypertension / blood
  • Hypertension / epidemiology
  • Hypertension / genetics*
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic / genetics*
  • Promoter Regions, Genetic / genetics*
  • Receptors, Bradykinin / genetics*
  • Receptors, Bradykinin / physiology*
  • Sequence Analysis, DNA

Substances

  • Receptors, Bradykinin